3-151340653-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_022788.5(P2RY12):​c.-72T>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.849 in 152,618 control chromosomes in the GnomAD database, including 54,992 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.85 ( 54843 hom., cov: 33)
Exomes 𝑓: 0.83 ( 149 hom. )

Consequence

P2RY12
NM_022788.5 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.10

Publications

7 publications found
Variant links:
Genes affected
P2RY12 (HGNC:18124): (purinergic receptor P2Y12) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]
MED12L (HGNC:16050): (mediator complex subunit 12L) The protein encoded by this gene is part of the Mediator complex, which is involved in transcriptional coactivation of nearly all RNA polymerase II-dependent genes. The Mediator complex links gene-specific transcriptional activators with the basal transcription machinery. [provided by RefSeq, May 2010]
MED12L Gene-Disease associations (from GenCC):
  • Nizon-Isidor syndrome
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.878 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
P2RY12NM_022788.5 linkc.-72T>C 5_prime_UTR_premature_start_codon_gain_variant Exon 2 of 3 ENST00000302632.4 NP_073625.1 Q9H244A8K7T1
P2RY12NM_022788.5 linkc.-72T>C 5_prime_UTR_variant Exon 2 of 3 ENST00000302632.4 NP_073625.1 Q9H244A8K7T1
MED12LNM_001393769.1 linkc.2251-9406A>G intron_variant Intron 16 of 44 ENST00000687756.1 NP_001380698.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
P2RY12ENST00000302632.4 linkc.-72T>C 5_prime_UTR_premature_start_codon_gain_variant Exon 2 of 3 1 NM_022788.5 ENSP00000307259.4 Q9H244
P2RY12ENST00000302632.4 linkc.-72T>C 5_prime_UTR_variant Exon 2 of 3 1 NM_022788.5 ENSP00000307259.4 Q9H244
MED12LENST00000687756.1 linkc.2251-9406A>G intron_variant Intron 16 of 44 NM_001393769.1 ENSP00000508695.1 A0A8I5KX78

Frequencies

GnomAD3 genomes
AF:
0.849
AC:
129068
AN:
152064
Hom.:
54813
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.862
Gnomad AMI
AF:
0.758
Gnomad AMR
AF:
0.867
Gnomad ASJ
AF:
0.879
Gnomad EAS
AF:
0.849
Gnomad SAS
AF:
0.900
Gnomad FIN
AF:
0.842
Gnomad MID
AF:
0.959
Gnomad NFE
AF:
0.832
Gnomad OTH
AF:
0.880
GnomAD4 exome
AF:
0.828
AC:
361
AN:
436
Hom.:
149
Cov.:
0
AF XY:
0.837
AC XY:
221
AN XY:
264
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
4
AN:
4
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.826
AC:
352
AN:
426
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
1.00
AC:
2
AN:
2
Other (OTH)
AF:
0.750
AC:
3
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.849
AC:
129152
AN:
152182
Hom.:
54843
Cov.:
33
AF XY:
0.851
AC XY:
63317
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.862
AC:
35792
AN:
41536
American (AMR)
AF:
0.867
AC:
13247
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.879
AC:
3051
AN:
3472
East Asian (EAS)
AF:
0.850
AC:
4392
AN:
5170
South Asian (SAS)
AF:
0.900
AC:
4343
AN:
4826
European-Finnish (FIN)
AF:
0.842
AC:
8927
AN:
10602
Middle Eastern (MID)
AF:
0.952
AC:
280
AN:
294
European-Non Finnish (NFE)
AF:
0.832
AC:
56583
AN:
67984
Other (OTH)
AF:
0.875
AC:
1849
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1030
2059
3089
4118
5148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.846
Hom.:
70029
Bravo
AF:
0.850
Asia WGS
AF:
0.837
AC:
2910
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.10
DANN
Benign
0.63
PhyloP100
-1.1
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3821667; hg19: chr3-151058441; COSMIC: COSV56381334; COSMIC: COSV56381334; API